Jose Montes
Ophthalmology · San Juan, PRNPI 1518928498
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by AbbVie at 59.9% of the total. Among ophthalmology clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 301 payments — averaging $1315.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$237K
- Galderma Laboratories, L.p.$112K
- Merz North America, Inc.$40K
- Galderma Research & Development, LLC$4K
- Endo Pharmaceuticals Inc.$3K
- Revance Therapeutics, Inc.$117
- plus $109 from 2 others
Across 118 payments — averaging $12,016 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1M
- Merz North America, Inc.$315K
- Endo Pharmaceuticals Inc.$51K
- Galderma Laboratories, L.p.$23K
What the payments were for
- Consulting fees$214,43954%
- Speaking & faculty fees$122,18131%
- Travel & lodging$50,45913%
- Food & beverage$8,7712%
- Education$800%
- Gifts$770%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 159 | $237,054 |
| Galderma Laboratories, L.p. | 75 | $112,312 |
| Merz North America, Inc. | 45 | $39,994 |
| Galderma Research & Development, LLC | 1 | $3,500 |
| Endo Pharmaceuticals Inc. | 18 | $2,923 |
| Revance Therapeutics, Inc. | 1 | $117 |
| Lumenis, Inc | 1 | $57 |
| Alcon | 1 | $52 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$47,983
- BOTOX COSMETIC$46,658
- XEOMIN$20,566
- NATRELLE SALINE-FILLED BREAST IMPLANTS$3,500
- KYBELLA$1,950
- DAXXIFY$117
- DYSPORT$113
How this compares
$396,008 in reported general payments places this provider in the 95th percentile of 214 ophthalmology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorometholone | 21 | $1,274 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 31 | $1,198 |
| ErythromycinErythromycin Base | 41 | $672 |
| Dexamethasone | 35 | $311 |
| Losartan Potassium | 19 | $121 |
| Atorvastatin Calcium | 13 | $93 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in San Juan
- Maria Berrocal FernandezSan Juan$547K
- Juan Nevarez MarreroSan Juan$19K
- Natalio Izquierdo EncarnacionSan Juan$16K
- Ian PiovanettiSan Juan$11K
- Jaime Bravo CastroSan Juan$8K
- Ernesto CollazoSan Juan$7K
- Gustavo HernandezSan Juan$5K
- Victor VillegasSan Juan$5K
- Gabriela Trabal YulfoSan Juan$4K
- Esteban Vazquez-ValenciaSan Juan$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.